Commentary on 'Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis' by Preiss et al.

Diabetes and Vascular Disease Research

Volumn 9, Issue 1, 2012, Pages 78-

  Marx, Nikolaus ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DRUG MEGADOSE; FOLLOW UP; HUMAN; INCIDENCE; MORTALITY; NOTE; RISK ASSESSMENT;

DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; META-ANALYSIS AS TOPIC; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS;

EID: 83455258076     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164111430337     Document Type: Note

References (2)

1. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials. Lancet. 2010 ; 375: 735-742
2. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis. JAMA. 2011 ; 305: 2556-2564